Biomedicine
Vital Therapies Closes $28.1 Million Financing
Published in Blood Weekly, September 27th, 2007
Vital Therapies, Inc. (VTI), announced the completion of a $28.1 million Series C financing. The new capital will support continued developed of ELAD(TM), the world's only human cell-based artificial liver. The financing was led by Versant Ventures which was joined by new investors Delphi Ventures, HBM BioMed China and DFJ DragonFund China. Also participating were existing investors MedVenture Associates, Valley Ventures, Toucan Capital and Heights Capital. Ross Jaffe, M.D., of Versant Ventures has joined VTI's board of directors, representing the Series C investors.
Terry Winters, Ph.D., Chairman and CEO said, "These experienced medical investors recognize that liver...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-09-27)
More Articles from Blood Weekly
- Blood Safety
Scientists, physicians present latest findings in 'personalized' cancer treatment and prevention - Portal Hypertension
Preventing variceal bleeding - Artificial Organs
Built by the Giants of Medicine, CardioWest Artificial Heart Celebrates 60th Birthday - Biomedicine
Blood bank representatives from throughout Spain attend the Progenika BLOODchip Workshop - Biopharmaceuticals
AVI BioPharma Drug Demonstrates Strong Survival Benefits and Elimination of Ebola Virus in Animals - Biosafety
Midwest Research Institute Launches Center for Biological Safety and Security (CBS2) - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
